iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 New Demand in an Old Market Decoding the Buzz Around Weight-loss

Results vary and no particular amount of weight loss or health improvement is guaranteed

Problem 1: You have a 20 mg/mL vial and need 7.5 mg

Pierre, medical weight-loss specialist at Hartford HealthCare Digestive Health Institute

Furthermore, tirzepatide has shown longer titration periods in clinical practice, delaying attainment of full maintenance doses and potentially dampening early cardiovascular benefits 28

Retatrutide is an investigational weight loss medication that targets GLP-1, GIP, and glucagon receptors, potentially making it more effective than tirzepatide, which only targets GLP-1 and GIP

Wang J, Zhang Z, Liu X, et al